Watchlist Price Alert

Evolent Health Inc. (EVH)

NYSE: EVH · Real-Time Price · USD

10.78

0.33 (3.16%)

At close: May 08, 2025, 3:59 PM

11.20

3.90%

Pre-market: May 09, 2025, 08:22 AM EDT

3.16% (1D)

Bid	10.4
Market Cap	1.27B
Revenue (ttm)	2.55B
Net Income (ttm)	-61.62M
EPS (ttm)	-0.82
PE Ratio (ttm)	-13.15
Forward PE	17.97
Analyst	Buy

Ask	11.25
Volume	2,139,946
Avg. Volume (20D)	2,536,919
Open	10.48
Previous Close	10.45
Day's Range	10.48 - 10.97
52-Week Range	8.35 - 33.63
Beta	1.04

About EVH

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol EVH

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for EVH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

New

Evolent Health has released their quartely earnings on May 8, 2025:

Revenue of $483.65M misses estimates by $227.69M, with -24.39% YoY decline.

EPS of 0.06 misses estimates by -0.15, with -82.35% YoY decline.

Why Price Moved

3 months ago

-9.77%

Evolent Health shares are trading lower after RBC ... Unlock content with Pro Subscription

5 months ago

+13.25%

Evolent Health shares are trading higher. Barclays maintained an Overweight rating on the stock.

News

17 hours ago · zacks.com

Evolent Health (EVH) Q1 Earnings Lag Estimates

Evolent Health (EVH) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.34 per share a year ago.

2 days ago · zacks.com

Wall Street Analysts Believe Evolent Health (EVH) Could Rally 53.33%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 53.3% in Evolent Health (EVH). While the effectiveness of this highly sought-after metric is questionable, the ...

2 months ago · seekingalpha.com

Evolent Health, Inc. (EVH) Q4 2024 Earnings Call Transcript

Evolent Health, Inc. (NYSE:EVH ) Q4 2024 Earnings Conference Call February 20, 2025 5:00 PM ET Company Participants Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Offi...

2 months ago · zacks.com

Evolent Health (EVH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Evolent Health (EVH) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street...

2 months ago · zacks.com

Evolent Health (EVH) Reports Q4 Loss, Lags Revenue Estimates

Evolent Health (EVH) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.23 per share a year ago.

2 months ago · zacks.com

Evolent Health (EVH) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Beyond analysts' top -and-bottom-line estimates for Evolent Health (EVH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the q...

2 months ago · zacks.com

Earnings Preview: Evolent Health (EVH) Q4 Earnings Expected to Decline

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.